Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annu...(nties relating to theforward-looking sta...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Paclitaxel/Carboplatin Results at iSBTc Annual Meeting
Date:10/23/2008
nties relating to the forward-looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as required by applicable laws.
'/>"/>
| SOURCE Oncolytics Biotech Inc. Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
Breaking Biology Technology:Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property 2Reportlinker Adds Pharmacodynamic Assays 2Reportlinker Adds Pharmacodynamic Assays 3Reportlinker Adds Pharmacodynamic Assays 4Vivakor Announces Mechanics of Dividend Distribution 2Vivakor Announces Mechanics of Dividend Distribution 3Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 2Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project 3
[0] Finn, Warnke & Gayton Announces A New Service For Biotechnology Firms - A Platform To Sell Intellectual Property[0] Reportlinker Adds Pharmacodynamic Assays[0] Vivakor Announces Mechanics of Dividend Distribution[0] Millipore Sponsors Three Academic Memberships for the MetaMiner Stem Cell Project
Other Biology Technology:Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care 2CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies 2CEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical Studies 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 2PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 3PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 4PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 5PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 6PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research 7
Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer CareCEL-SCI's L.E.A.P.S. Technology Shows Potential to Treat Swine Influenza in Preclinical StudiesPharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research
Breaking Biology News(10 mins):Carnegie Mellon researchers receive grant 2Supportive materials will help regenerate heart tissue 2MSU researcher unveils new approach to treat lower back pain 2Gays Bisexuals Seek More Psych Services 54506 1Gays Bisexuals Seek More Psych Services 54506 2Chiropractors Focus on Patients Best Interest 54503 1Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 1Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 2Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 3Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 4Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 5Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 6Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 7Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs 28ACRHD 29 Meeting 4851 8
Other Biology News:Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States 2Ingram Micro to Distribute New Fujitsu Biometric Login Products for Novell eDirectory in United States 3Methadone even at therapeutic levels can kill 2Methadone even at therapeutic levels can kill 3Evolution of the sexes: What a fungus can tell us 2
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |